Schedule 13G ownership disclosure

JASPER THERAPEUTICS INC

Voting Common Stock, par value $0.0001 · CUSIP: 471871202

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Qiming U.S. Healthcare Fund II, L.P.

    Shares: 928,964.00 · Class: 3.3%

  • Qiming U.S. Healthcare GP II, LLC

    Shares: 928,964.00 · Class: 3.3%

  • Mark McDade

    Shares: 928,964.00 · Class: 3.3%

  • GARY E RIESCHEL

    Shares: 928,964.00 · Class: 3.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001765710-25-000005
Form type
SCHEDULE 13G/A
Filer
Jasper Therapeutics, Inc.
CIK
CIK 1788028
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub